Steven Manning
Family Medicine · Williamston, NCNPI 1932367521
Payments from drug & device makers
Across 87 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$277
- Pfizer$245
- AbbVie$146
- Lilly USA, LLC$117
- Eisai Inc.$65
- Boston Scientific$59
- plus $612 from 19 others
What the payments were for
- Food & beverage$1,48898%
- Education$322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $277 |
| Pfizer | 14 | $245 |
| AbbVie | 7 | $146 |
| Lilly USA, LLC | 6 | $117 |
| Eisai Inc. | 4 | $65 |
| Boston Scientific | 2 | $59 |
| Corium, LLC | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Amgen | 4 | $48 |
| Novartis | 3 | $48 |
| Corcept Therapeutics | 2 | $48 |
| Merck | 3 | $43 |
| Boehringer Ingelheim | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Sunovion Pharmaceuticals Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Dexcom, Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Abbott | 1 | $22 |
| GSK | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| AstraZeneca | 1 | $11 |
How this compares
$1,521 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 93 | $103,561 |
| EliquisApixaban | 96 | $61,881 |
| JardianceEmpagliflozin | 89 | $54,381 |
| TrulicityDulaglutide | 40 | $37,442 |
| MyrbetriqMirabegron | 82 | $36,934 |
| XareltoRivaroxaban | 36 | $31,767 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $28,205 |
| RybelsusSemaglutide | 19 | $19,729 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 57 | $18,361 |
| MounjaroTirzepatide | 18 | $16,138 |
| JanuviaSitagliptin Phosphate | 17 | $12,635 |
| Repatha SureclickEvolocumab | 12 | $10,798 |
| Novolog FlexpenInsulin Aspart | 20 | $10,156 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 41 | $9,159 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $6,464 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $277 | $123,290112 claims |
| PfizerEliquis, Abrysvo | $245 | $80,242153 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $43 | $59,614101 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $117 | $53,58058 claims |
| GSKTrelegy Ellipta, Shingrix, Anoro Ellipta | $17 | $42,58092 claims |
| MerckJanuvia | $43 | $12,63517 claims |
| AbbVieSynthroid | $146 | $2,98238 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Williamston
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.